Enovis (ENOV) Net Income Growth (5y) (2015 - 2026)
Enovis (ENOV) Net Income Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.69 Bn | 175.40 Bn | 6.27 Bn |
| 2 | Stryker | 128.95 Bn | 126.07 Bn | 3.81 Bn |
| 3 | Medtronic | 108.07 Bn | 98.85 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.93 Bn | 66.47 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.11 Bn | 44.44 Bn | 1.29 Bn |
| 6 | Dexcom | 28.33 Bn | 27.21 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.89 Bn | 25.60 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.42 Bn | - |
| 9 | Koninklijke Philips | 24.05 Bn | 20.92 Bn | 2.07 Bn |
| 10 | Enovis | 1.62 Bn | 1.59 Bn | 365.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | -14.88% |
| Dec 31, 2025 | 25.93% |
| Oct 3, 2025 | 56.74% |
| Jul 4, 2025 | 54.76% |
| Apr 4, 2025 | 48.23% |
| Dec 31, 2024 | 14.97% |
| Sep 27, 2024 | -24.30% |
| Jun 28, 2024 | 82.93% |
| Dec 31, 2023 | -74.81% |
| Sep 29, 2023 | -2.18% |
| Jun 30, 2023 | 22.79% |
| Mar 31, 2023 | -15.30% |
| Dec 31, 2022 | -39.59% |
| Sep 30, 2022 | -17.64% |
| Jul 1, 2022 | -35.86% |
| Apr 1, 2022 | 77.36% |
| Dec 31, 2021 | 111.56% |
| Oct 1, 2021 | 46.91% |
| Jul 2, 2021 | 295.91% |
| Apr 2, 2021 | 132.67% |